This document addresses the use of multi-biomarker disease activity (MBDA) blood testing that produces a score designed to assess rheumatoid arthritis (RA) disease activity. An example is the Vectra^® DA blood test (Crescendo Bioscience, Inc., South San Francisco, CA).

Position Statement

Investigational and Not Medically Necessary:

The use of multi-biomarker disease activity blood testing for rheumatoid arthritis (for example, Vectra DA) is considered investigational and not medically necessary in all situations.